Arkolith/Insider Trading/VRDN/Form 4/A

Violin Jonathan

Chief Executive Officer, DirectorViridian Therapeutics, Inc.\DE (VRDN) · full profile →Form 4/A · filed Feb 7, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.8M
Net Open-Market Flow
-$1.8M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2023Sell(S)50K$36.80$1.8M481K
Feb 2, 2023Option exercise(M)50K$0.15$8K531K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 2, 2023Option exercise(M)50K—$0239K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0000899243-23-004233) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML